AngioDynamics gets FDA clearance for pulmonary embolism treatment device (NASDAQ:ANGO)

AngioDynamics gets FDA clearance for pulmonary embolism treatment device (NASDAQ:ANGO)

AngioDynamics (NASDAQ:ANGO) has secured a label expansion for its AlphaVac F1885 System from the U.S. Food and Drug Administration (FDA).

The expanded FDA indication allows for the utilization of the AlphaVac F1885 System for the treatment of pulmonary embolism (PE), which affects around 900,000 people in the U.S. every year and is the third leading cause of cardiovascular mortality in the nation.

The post AngioDynamics gets FDA clearance for pulmonary embolism treatment device (NASDAQ:ANGO) first appeared on Investorempires.com.

 

Is a New Dogecoin (DOGE) Bull Run on the Horizon? These Analysts Think so | Investorempires.com

Read More | TL;DR Dogecoin experiences a 10% weekly price decline after the recent bull run, following a broader market correction. Predictions for DOGE’s price include significant increases, with discussions on its potential for reaching new ATH. Dogecoin (DOGE) is among the worst-affected cryptocurrencies (from the top 10 list) from the latest market correction, with […]